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ABSTRACT Recent studies implicate a role for cell mechanics in cancer progression. The ep-
ithelial-to-mesenchymal transition (EMT) regulates the detachment of cancer cells from the 
epithelium and facilitates their invasion into stromal tissue. Although classic EMT hallmarks 
include loss of cell–cell adhesions, morphology changes, and increased invasion capacity, little 
is known about the associated mechanical changes. Previously, force application on integrins 
has been shown to initiate cytoskeletal rearrangements that result in increased cell stiffness 
and a stiffening response. Here we demonstrate that transforming growth factor β (TGF-β)–
induced EMT results in decreased stiffness and loss of the normal stiffening response to force 
applied on integrins. We find that suppression of the RhoA guanine nucleotide exchange fac-
tors (GEFs) LARG and GEF-H1 through TGF-β/ALK5–enhanced proteasomal degradation me-
diates these changes in cell mechanics and affects EMT-associated invasion. Taken together, 
our results reveal a functional connection between attenuated stiffness and stiffening re-
sponse and the increased invasion capacity acquired after TGF-β–induced EMT.
INTRODUCTION
The reciprocity of mechanical information between cells and their 
extracellular environment has increased appreciation for the role 
of physics in cancer metastasis (Butcher et al., 2009). In this com-
plex progression, cancer cells detach from the primary tumor, 
invade the surrounding stromal space, transmigrate the vascular 
system, and establish secondary tumors at distal sites. Specific me-
chanical phenotypes are likely adopted to enable cells to navigate 
successfully the mechanical environments encountered during me-
tastasis (Wirtz et al., 2011). Epithelial-to-mesenchymal transition 
(EMT) is an essential physiological process that drives adherent, 
immotile cells to lose polarity and increase migration. Recently ab-
normal reactivation of EMT has been implicated in the detachment 
of cancer cells from epithelial tissue and their subsequent invasion 
into stromal tissue (Yilmaz and Christofori, 2009; Taylor et al., 
2010). The transforming growth factor β (TGF-β) superfamily of 
growth factors, one of the primary drivers of EMT, initiates this 
process by altering gene expression (Ranganathan et al., 2007), 
inducing loss of cell–cell adhesions (Vogelmann et al., 2005), 
promoting changes to cytoskeletal structure (Moustakas and 
Stournaras, 1999; Hubchak, 2003), and increasing motility and 
invasion (Oft et al., 1998; Gordon et al., 2009). These changes in 
cytoskeletal structure and increased interaction with the extracel-
lular matrix (ECM) implicate a role for altered cell mechanics dur-
ing EMT (Yilmaz and Christofori, 2009).
Extensive remodeling of the ECM occurs in cancer (Levental 
et al., 2010), resulting in tumors being stiffer (Paszek et al., 2005) and 
more heterogeneous than normal tissue (Plodinec et al., 2012); 
therefore cancer cells moving through tumor ECM experience stiff-
ness gradients not typically experienced by normal epithelial cells. 
Integrins are transmembrane, mechanosensitive receptors that pro-
vide an essential physical connection between the ECM and the 
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(NMuMG) epithelial cells, a well-established TGF-β–induced EMT 
model (Piek et al., 1999; Yu et al., 2002; Xie et al., 2004). A mag-
netic tweezers system (Fisher et al., 2006; O’Brien et al., 2008) was 
then used to apply force via integrins (Matthews et al., 2006; 
Guilluy et al., 2011) to the cytoskeleton through externally attached 
paramagnetic beads coated with fibronectin (FN). The viscoelastic 
response of a cell was observed by monitoring the displacement of 
a bound bead over time during force application (Figure 1A). To 
quantify the mechanical phenotype in terms of stiffness and stiffen-
ing response, we calculated the time-dependent compliance of the 
cell and fitted it to a Jeffrey model for viscoelastic liquids (Figure 
1B; Larson 1999). The spring constant obtained during the first 
pulse of force provided a measure of stiffness, and by normalizing 
the spring constants of subsequent force pulses to the first, we 
obtained the stiffness-response to force, or stiffening response. 
Two classifications of mechanical response were observed: a stiff-
ening response (Figure 1C) and a softening response (Figure 1D). 
TGF-β–induced EMT was verified by monitoring reduced E-cad-
herin levels (see later discussion of Figure 4A) and actin reorganiza-
tion (insets, Figure 2, A and B).
actin cytoskeleton (Wang et al., 1993) during cell adhesion and mi-
gration. Studies have shown that cells respond to force on integrins 
by generating a stiffening response to resist the applied force and 
maintain mechanical reciprocity (Matthews et al., 2006; Lessey et al., 
2012). We demonstrated that mechanical response to force is regu-
lated by the activation of the small GTPase RhoA through specific 
guanine nucleotide exchange factors (GEFs) in fibroblasts (Guilluy 
et al., 2011). Although RhoA and its effectors have been linked to 
cancer (Lazer and Katzav, 2011), the molecular mechanisms that 
regulate its activity and involvement in particular steps of the meta-
static cascade, such as during EMT, are not well understood. Here 
we investigate the mechanistic links between cell stiffness and stiff-
ening response and the increased invasion capacity acquired after 
TGF-β–initiated EMT cancer progression.
RESULTS
TGF-β–induced EMT alters stiffness and stiffness response 
to force on integrins
To determine the effect of EMT on cell stiffness and stiffening re-
sponse, we induced EMT in normal murine mammary gland 
FIGURE 1: Modeling of cell stiffness and stiffness response. (A) Schematic of the magnetic tweezers experiment: a 
50-pN force was applied for 5 s, followed by a 10-s relaxation time, for a total of eight pulls. The time-dependent 
displacement for a typical bead is shown below the force regimen. (B) The time-dependent compliance (black data 
points) is calculated from the displacement of a bead and the applied force. The Jeffrey model (inset) is a mechanical 
circuit that models the elastic (or stiffness, G) and viscous (η 1 and η2) responses for a viscoelastic liquid during force 
application. The Jeffrey model (blue line) was used to quantify the stiffness of the cell as measured during force 
application. In experiments, the cell stiffness was defined to be the stiffness obtained in modeling the compliance of the 
cell during the first pulse of force. (C, D) Compliance signatures for representative examples of (C) cell stiffening and 
(D) cell softening, where time progression is encoded by increasing intensity of red, such that black is the compliance 
during the first pulse of force. To examine the stiffness of cells in response to force, we used the Jeffrey model to 
quantify the stiffness for each pulse of force during the 2-min experiment. The obtained stiffness measurements were 
normalized to the stiffness derived from the first pulse of force (G1) to give relative force response fractions G 2/G1 
through G 8/G1. The full, nonoverlapping compliance signatures are provided in Supplemental Figure S1, C and D.
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EMT are specific to NMuMG cells or to EMT 
in general, we examined human pancreatic 
carcinoma (PANC-1) cells, which undergo 
EMT in response to bone morphogenetic 
protein-2 (BMP-2; Gordon et al., 2009) and 
TGF-β. Similar to post-EMT NMuMG cells, 
PANC-1 cells exhibited decreased stiffness 
when treated with BMP-2 (Figure 2E) and 
TGF-β (Supplemental Figure S1C) and a loss 
of the normal stiffening response to force on 
integrins after 1 min (Figure 2F and Supple-
mental Figure S1D, respectively).
To determine whether the decrease in 
stiffness observed after EMT was a result of 
the force magnitude applied during the 
magnetic tweezers (active microrheology) 
assay, we performed an external passive mi-
crorheology assay to measure the basal stiff-
ness of NMuMG cells before and after TGF-
β–initiated EMT. Consistent with observations 
with the magnetic tweezers assay, measure-
ment of the thermal motion of FN-coated 
beads revealed a threefold decrease in cell 
stiffness upon TGF-β treatment (Figure 3, A 
and B).
To dynamically probe areas of increasing 
and variable stiffness, as seen in cancer ECM 
(Butcher et al., 2009), cells use integrin-as-
sociated focal adhesions as individual and 
autonomous stiffness sensors (Plotnikov 
et al., 2012). As such, to examine whether 
specific binding to integrins was required to 
elicit a stiffening response during force ap-
plication, we used poly-d-lysine (PDL)–
coated beads, which bind nonspecifically to 
the cell surface based on charge. In contrast 
to the response observed with FN-coated 
beads and consistent with findings in en-
dothelial cells (Collins et al., 2012), force ap-
plied to PDL-coated beads did not evoke a 
stiffening response (Supplemental Figure 
S1E). Thus the stiffening response to force 
on FN-coated beads is specific to integrin-
mediated attachment to the cytoskeleton.
Cells undergoing EMT undergo changes 
in the expression of many receptors 
(Ranganathan et al., 2007). To exclude the 
possibility that reduction in cell stiffness and 
stiffening response during EMT was due to 
loss of integrin expression, we examined ex-
pression of α5 and β1 integrins, the primary 
receptors for FN. We observed no signifi-
cant reduction in either α5 or β1 level post-EMT in NMuMGs (Sup-
plemental Figure S1F), indicating that the reduction in mechanical 
properties was not due to reduction of FN receptor expression. 
Taken together, these data indicate that cells undergo a reduction in 
stiffness and stiffening response after EMT.
RhoA GEF expression and recruitment to the adhesion 
complex during force is lost after TGF-β–induced EMT
Forces applied to integrins increase RhoA activity via Rho GEFs and, 
in turn, induce a stiffening response through reinforcement and 
Mechanical characterization demonstrated a population-level 
shift toward lower stiffness in TGF-β–treated NMuMG cells compared 
with untreated cells (Figure 2, A and B). In addition, the average stiff-
ness of mesenchymal cells was threefold less than that of epithelial 
cells (Figure 2C). In response to successive pulses of force, epithelial 
cells increased their stiffness (Figure 2D) significantly after 1 min or 
five pulses of force (Figure 2D). After TGF-β–induced EMT, this stiff-
ening response to force was lost, indicating that mesenchymal cells 
are unable to fully adjust their stiffness in response to external force 
(Figure 2D). To investigate whether these mechanical changes after 
FIGURE 2: Stiffness and stiffness response to force decrease during TGF-β induced EMT. 
(A, B) NMuMG cells were treated with 100 pM TGF-β for 48 h to induce EMT. Histogram of 
NMuMG cell stiffness for (A) epithelial state (untreated) and (B) mesenchymal-state. Insets, 
fluorescence images are cells stained with phalloidin to show actin structures. (C) Average cell 
stiffness of NMuMG cells for untreated (n = 90) and TGF-β treated (n = 98) populations. 
**p < 0.001. (D) Average stiffness response for untreated (n = 30) and TGF-β treated (n = 25) 
populations. #Stiffness difference of Gx from G1 at the p < 0.05 level. *Stiffness response (Gx/G1) 
difference between conditions at the p < 0.05 level. (E) PANC-1 cells were treated with 300 ng/
mL BMP-2 for 72 h to induce EMT. Average PANC-1 cell stiffness for untreated (n = 86) and 
BMP-2 treated cells (n = 61). *Stiffness difference relative to untreated cells at the p < 0.05 level. 
(F) Average PANC-1 stiffness response for untreated (n = 20) and BMP-2 treated (n = 15) cells. 
#Stiffness difference of Gx from G1 at the p < 0.05 level. *Stiffness response (Gx/G1) difference 
between conditions at the p < 0.05 level. Error bars represent SEM; data were collected from 
three independent experiments.
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cells, respectively (Figure 4, B and C). These 
findings suggested specific roles for LARG 
and GEF-H1 in cell stiffness and stiffening 
response during EMT.
To test whether EMT affects GEF recruit-
ment to sites of force application, we devel-
oped a rotating permanent magnet device 
(Supplemental Figure S2A) to generate a 
force regimen consistent in magnitude, duty 
cycle, and frequency with that produced by 
the magnetic tweezers (Supplemental Figure 
S2B) and pulsatile forces to the cells via ex-
ternally attached FN-coated beads. After 
force stimulation, we separated the bead 
fraction containing adhesion complex pro-
teins from the whole lysate (Guilluy et al., 
2011) and found that LARG and GEF-H1 
were recruited in a time-dependent manner 
in epithelial-state NMuMG cells. In contrast, 
TGF-β–induced EMT abrogated this time-
dependent recruitment of LARG and GEF-
H1 (Figure 5A). Examination of p114, an-
other RhoGEF, showed no recruitment to 
the adhesion complex and was unchanged 
after EMT (Figure 5A), suggesting that LARG 
and GEF-H1 have specific roles in force 
transduction during EMT. Similar loss of 
force-dependent recruitment of LARG and GEF-H1 was found in 
PANC-1 cells treated with BMP-2 (Figure 5B).
Given our observations of post-EMT reduction in LARG and 
GEF-H1 expression and force-dependent recruitment, we hypoth-
esized that RhoA activity in response to force would also be re-
duced after EMT. Using glutathione S-transferase–RBD-coated 
beads to pull down active RhoA from cell lysates (Guilluy et al., 
2011), we found that epithelial-state NMuMG cells activated RhoA 
within 1 min of force application and that this response was lost 
rearrangement of the cytoskeleton and adhesion complexes 
(Guilluy et al., 2011). On the basis of reduction of stiffness and stiff-
ening response after EMT (Figure 2, C and D), we hypothesized that 
this could be caused by altered RhoA activity through down-regula-
tion of specific Rho GEFs. Indeed, expression levels of two Rho 
GEFs, LARG and GEF-H1, were significantly reduced after EMT, 
whereas expression of p114, another Rho GEF, was unchanged 
(Figure 4A). Similar results were obtained in TGF-β–induced EMT in 
OVCA420 and PANC-1 cells and BMP-2–induced EMT in PANC-1 
FIGURE 3: Stiffness of NMuMG cells measured by passive microrheology. (A) Mean-squared 
displacement (MSD) of 2 μm, FN-coated beads as a function of time scale between 0.1 and 10 s 
for NMuMG cells with or without TGF-β treatment; each curve is the ensemble average of cell 
populations: untreated (n = 1050) and TGF-β treated (n = 1010). MSD curves show a slope of 
<1 (illustrated by the black guide line), indicating subdiffusive viscoelastic response of beads 
anchored to the cortical actin cytoskeleton through integrin receptors (Wirtz, 2009). Data were 
taken using a high-throughput microscopy system described previously (Spero et al., 2008). 
Error bars represent SEM; the MSD of beads attached to untreated and TGF-β treated NMuMG 
were statistically significant at *p < 0.001 for all time scales. (B) Effective stiffness, G′ (Pa), of 
NMuMG cells with or without TGF-β treatment at the 1-s time scale. Using the MSD trajectories 
computed in Supplemental Figure S1B, we calculated the complex, frequency-dependent shear 
modulus, G*(ω), using the generalized Stokes–Einstein relation, and the elastic contribution is 
shown at the 1-s time scale.
FIGURE 4: LARG and GEF-H1 expression decreases during EMT. (A, B) Indicated cell lines were treated with 100 pM 
TGF-β for 48 or 72 h. Cells were then lysed, and protein expression levels were analyzed by Western blot. A 
representative blot of four independent experiments. (C) PANC-1 cells were treated with 300 ng/ml BMP-2 for 48 and 
72 h. Cells were then lysed, and protein expression levels were analyzed by Western blot. A representative blot of four 
independent experiments.
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indicating a requirement for ALK5 in maximal regulation of RhoGEF 
expression (Figure 6A). In contrast, blocking the mitogen-activated 
protein kinase kinase (MEK)/extracellular signal-regulated kinase 
pathway with U0126 (Alk et al., 2002), which can also mediate 
TGF-β responses (Xu et al., 2009), did not ameliorate TGF-β–
dependent decreases in LARG and GEF-H1 levels in NMuMG cells 
(Figure 6A).
Given that LARG and GEF-H1 have been shown to regulate cell 
mechanics (Guilluy et al., 2011) and expression of LARG and GEFH-1 
was regulated via an ALK5-dependent mechanism, we hypothesized 
that the effect of TGF-β on cell mechanics would be dampened 
upon ALK5 inhibition. Using the ALK5 inhibitor SB-431542 to par-
tially restore LARG and GEF-H1 levels (Figure 6A), we find that 
NMuMG cell stiffness (Figure 6B) and stiffness response (Figure 6C) 
were significantly increased compared with cells treated with only 
TGF-β. These results directly implicate canonical TGF-β signaling 
mechanisms downstream of ALK5 in regulating cell mechanics dur-
ing EMT.
RhoA and the RhoA GEF Net1A have been shown to be down-
regulated during TGF-β–induced EMT via a microRNA-based mech-
anism (Kong et al., 2008; Moustakas and Heldin, 2012) that acts on 
after EMT induction (Figure 5C). Of interest, this 1-min time scale 
was consistent with the point in which the stiffening response in 
epithelial-state cells becomes significant (Figure 2D). We also 
found that RhoA expression was significantly reduced after EMT, in 
line with previous observations (Ozdamar et al., 2005). Taken to-
gether, the suppression of force-dependent RhoA activity and the 
loss of RhoA expression and force-dependent recruitment of LARG 
and GEF-H1 suggest that disruption of the Rho pathway plays a 
role in altered stiffness response to force during EMT.
TGF-β regulates Rho GEF expression during EMT by 
enhancing proteasomal degradation via activin receptor–
like kinase 5 signaling
TGF-β can regulate activation of the RhoA pathway via canonical 
(activin receptor–like kinase 5 [ALK5] dependent) and noncanonical 
(mitogen-activated protein kinase dependent) TGF-β signaling 
mechanisms (Bhowmick et al., 2001). To investigate how TGF-β 
regulates LARG and GEF-H1 expression during EMT, we used the 
ALK5 inhibitor SB-431542 (Alk et al., 2002) and found that ALK5 
inhibition partially rescued TGF-β–mediated LARG and GEF-H1 
protein down-regulation in both NMuMG and OVCA420 cells, 
FIGURE 5: LARG and GEF-H1 recruitment to adhesion complex during force decrease during TGF-β–induced EMT. 
(A, B) Effect of EMT on RhoA GEF recruitment in either NMuMG (A) or PANC-1 (B) cells. Indicated cells were incubated 
for 30 min with FN-coated beads (Guilluy et al., 2011) and stimulated with a force regimen (50 pN; 5 s force, 10 s 
recovery) using a rotating permanent magnet for different amounts of time (Materials and Methods). After magnetic 
separation of the adhesion complex, both the lysate and adhesion complex fractions were analyzed using Western 
blots. Representative of four independent experiments. Associated quantification of amount of protein in adhesion 
complex (bead-to-lysate ratios), relative to untreated cells without force stimulation, is provided. (C) Effect of EMT on 
RhoA activation in NMuMG cells. Cells were stimulated with a force regimen using a rotating permanent magnet as in 
A. RhoA activity in lysates was determined as described (Guilluy et al., 2011). Representative of three experiments. 
Associated quantification of amount of protein in adhesion complex (bead-to-lysate ratio), relative to untreated cells 
without force stimulation, is provided.
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(GFP) tag but lacking a 3′-UTR. We found that exogenous LARG and 
GEF-H1 were down-regulated to similar extents as their endoge-
nous counterparts (Figure 6D), suggesting that microRNAs may not 
play a significant role in the TGF-β–induced decreases of LARG and 
GEF-H1.
the 3′-untranslated region (UTR) to induce translational silencing of 
proteins (He and Hannon, 2004). To test whether microRNAs play a 
role in TGF-β down-regulation of LARG and GEF-H1, we examined 
the extent of down-regulation of exogenously expressed LARG or 
GEF-H1 cDNA containing an N-terminus green fluorescent protein 
FIGURE 6: TGF-β promotes proteasome degradation of LARG and GEF-H1 during EMT via Alk5. (A) Indicated cells were 
pretreated for 1 h with 10 μM SB-431542 (ALK5 inhibitor), 10 μM U0126 (MEK inhibitor), or dimethyl sulfoxide (DMSO; 
negative control), followed by treatment with 100 pM TGF-β for 48 h. (B) NMuMG cells were pretreated for 1 h with 
10 μM SB-431542 (ALK5 inhibitor) or DMSO, followed by treatment with 100 pM TGF-β for 48 h or DMSO. Average cell 
stiffness for DMSO (n = 55), DMSO and TGF-β (n = 84), and SB-431542 and TGF-β (n = 81) populations. *p < 0.01. Error 
bars represent SEM; data were collected from three independent experiments. (C) NMuMG cells were pretreated for 1 h 
with 10 μM SB-431542 (ALK5 inhibitor) or DMSO, followed by treatment with 100 pM TGF-β for 48 h or DMSO. Average 
stiffness response for DMSO (n = 31), DMSO and TGF-β (n = 20), and SB-431542 and TGF-β (n = 26) populations. 
*p < 0.05. Error bars represent SEM; data were collected from three independent experiments. (D) NMuMG cells 
transfected with GFP-tagged LARG or GEF-H1cDNA lacking the 3′-UTR were treated with TGF-β for 48 h. Lysates were 
immunoblotted to determine expression of endogenous and exogenous GFP-tagged LARG/GEFH1. (E) TGF-β treatment 
does not reduce mRNA levels of LARG or GEF-H1. mRNA levels determined by quantitative PCR were normalized to 
glyceraldehyde-3-phosphate dehydrogenase. Error bars represent SEM. The dashed line denotes untreated. (F) TGF-β 
promotes proteasome degradation of LARG and GEF-H1. (D) OVCA420 cells were treated for 72 h with TGF-β and with 
10 and 20 μM MG-132 or DMSO as control. (E) NMuMG cells treated with TGF-β for 48 h and 10 μM MG-132 or DMSO 
as control for the last 16 h of treatment for both D and E. Representative of at least three experiments.
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NMuMG cells were transfected with plasmids containing cDNA to 
encode GFP-tagged LARG and GEF-H1 to rescue the reduced ex-
pression (Figure 8A). Mechanical measurements were performed 
only on LARG- or GEF-H1–expressing cells, as identified by GFP 
expression. We found that restoring LARG or GEF-H1 expression 
rescued the 50% post-EMT reduction in cell stiffness to 70 and 80% 
of the GFP-control stiffness, respectively (Figure 8B). Similarly, 
restoring LARG or GEF-H1 expression rescues the 30% post-EMT 
reduction in stiffening response to 90% of the response observed in 
GFP-control cells (Figure 8C).
We previously observed that loss of LARG and GEF-H1 expres-
sion in epithelial cells increased migration and invasion (Figure 7, D 
and E). To determine whether restoring the expression of these 
GEFs also affects cell migration and invasion, we used fluorescence-
activated cell sorting (FACS) to isolate GFP-expressing cells and 
then performed migration and invasion assays with these cells. We 
found that overexpression of LARG or GEF-H1 fully suppressed 
EMT-induced increases in migration and invasion (Figure 8, D and E) 
compared with control GFP cells, thus establishing LARG and GEF-
H1 as being sufficient for the mechanical and invasion phenotypes 
obtained during TGF-β–initiated EMT.
DISCUSSION
To examine the role of cell mechanics in EMT, we used force-consis-
tent biophysical and biochemical assays to characterize the mecha-
nistic links between stiffness response and cell invasion during EMT. 
We demonstrate that epithelial-state cells respond to force on inte-
grins by evoking a stiffening response and that after EMT, mesen-
chymal-state cells have reduced stiffness but also lose the ability 
to increase their stiffness in response to force. Using loss- and gain-
of-function studies, we establish two RhoA activators, LARG and 
GEF-H1, as both necessary and sufficient mediators of the effect of 
EMT on stiffness and stiffness response. We determine that TGF-β 
mediates proteasome degradation of LARG and GEF-H1 via ALK5 
and that reduction of these RhoA activators contributes significantly 
to the increase in migration and invasion behavior during EMT. Here 
we discuss the potential utility of altered stiffness mechanics in EMT, 
the significance of GEFs and the RhoA pathway to mesenchymal 
cell invasion, and the mechanisms by which TGF-β interacts with the 
RhoA pathway during EMT.
In examining the mechanical phenotype adopted during EMT, 
we established that post-EMT cells have a decreased stiffness and 
stiffening response compared with epithelial-state cells. A full un-
derstanding of the biological significance of these mechanical 
changes will require additional investigation, but at present a few 
hypotheses can be described. First, these results support a model 
in which epithelial cells resist external deformation by mounting a 
stiffening response to maintain mechanical equilibrium and prevent 
potential injury (Glogauer, 1998; Matthews et al., 2006). During 
EMT and associated epithelium detachment, a stiffening response 
to force may lose its utility to mesenchymal-state cells, as adaptive 
stiffness near integrins may increase adhesion size and strength and 
thus hinder the adhesion turnover required for effective cell migra-
tion and invasion. Second, increasing evidence supports the long-
standing belief that a certain degree of deformability, or reduced 
stiffness, is required for metastatic cells to navigate the basement 
membrane and intravasate and extravasate the vascular system 
(Suresh et al., 2005; Wirtz et al., 2011). Third, an attenuated cortical 
stiffness and stiffening response to force after EMT may reduce the 
internal resistance that cell-generated forces act against to facilitate 
cancer cell invasion behavior. One consequence of reduced stiff-
ness is that for a given cell-generated force, post-EMT cells could 
Because TGF-β regulates the transcription of many genes during 
EMT (Xu et al., 2009), we examined whether EMT altered transcrip-
tion of LARG and GEF-H1. We found that although TGF-β caused 
down-regulation of E-cadherin, we observed no significant down-
regulation of LARG and GEF-H1 at the mRNA level (Figure 6E). 
Therefore we examined the role of the proteasome in regulating 
LARG and GEF-H1 levels, which has been shown to regulate TGF-
β–dependent levels of RhoA (Wang et al., 2003). We found that the 
proteasome inhibitor MG-132 was able to rescue down-regulation 
of LARG and GEF-H1 protein levels after TGF-β–induced EMT in 
both NMuMG and OVCA420 cells (Figure 6F). These data implicate 
proteasome-mediated regulation of the RhoGEFs LARG and 
GEFH-1 during EMT via an ALK5-dependent mechanism.
Epithelial-state cells partially adopt post-EMT mechanical 
and invasion phenotypes through silencing of LARG and 
GEF-H1
EMT marks the physical initiation of cancer progression as a cell 
detaches from the primary tumor and invades the surrounding 
stromal space. Alterations in the RhoA pathway have been impli-
cated in a variety of cancers (Simpson et al., 2004; Vega et al., 2011). 
However, whereas RhoA activation in some cancers is associated 
with increased invasion (Liao et al., 2012), in others, RhoA activation 
inhibits cell invasion (Bellovin et al., 2006). In addition, RhoA and its 
associated GEFs LARG and GEF-H1 have been shown to regulate 
the stiffening response to force applied on integrins (Guilluy et al., 
2011). On the basis of these and our findings that LARG and GEF-
H1 expression and force-dependent recruitment are reduced in 
multiple EMT models (Figures 4A and 5A) and that ALK5 inhibition 
reverses the TGF-β–mediated reduction in cell mechanics, we ex-
amined whether LARG and GEF-H1 down-regulation were sufficient 
for decreased stiffness and stiffening response to force. Using small 
interfering RNA (siRNA) to reduce GEF expression in NMuMG epi-
thelial-state cells (Figure 7A), we found that silencing LARG, GEF-
H1, or both significantly decreased cellular stiffness (Figure 7B) and 
stiffening response compared with control siRNA–treated cells 
(Figure 7C). In contrast, siRNA to p114 had no significant effect on 
stiffness (Figure 7B) or suppression of the stiffening response to 
force (Figure 7C), suggesting a specific role for LARG and GEF-H1 in 
determining these mechanical properties.
Given that we and others previously reported an inverse correla-
tion between cell stiffness and invasion (Swaminathan et al., 2011; 
Xu et al., 2012), we examined the effect of GEF silencing on migra-
tion and invasion using siRNA to deplete protein levels in epithelial-
state NMuMG cells. We found that silencing LARG, GEF-H1, or both 
simultaneously significantly increased cell migration and invasion 
(Figure 7, D and E) compared with control siRNA cells. In contrast, 
siRNA to p114 did not significantly alter cell migration or invasion 
(Figure 7, D and E). In line with these results, we found that specific 
silencing of LARG and GEF-H1 expression in epithelial cells in-
creases invasion capacity toward that of post-EMT mesenchymal 
cells.
Mesenchymal-state cells recover epithelial-state mechanical 
and invasion phenotypes through rescue of LARG or 
GEF-H1 expression
Our results indicate that LARG and GEF-H1 are necessary mediators 
of stiffness (Figure 7B) and stiffness response (Figure 7C). To exam-
ine whether down-regulation of LARG and GEF-H1 was necessary 
and sufficient to restore post-EMT loss of stiffness and stiffness re-
sponse phenotypes, we rescued GEF expression after EMT induc-
tion and performed mechanical and invasion assays. Post-EMT 
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tuned for mechanosensing (de Rooij et al., 2005; Guo et al., 2006). 
To dynamically probe areas of increasing and variable stiffness, as 
seen in cancer ECM (Butcher et al., 2009), cells use integrin-associ-
ated focal adhesions as individual and autonomous stiffness sensors 
(Plotnikov et al., 2012). Migration through these regions is believed 
to involve appropriate temporal regulation of cell-generated, 
exert higher actomyosin contractile forces to the ECM. Such in-
creased contractile forces have been shown to be correlated with 
cells of increasing metastatic potential (Kraning-Rush et al., 2012) 
and are specifically required for mesenchymal invasion in certain 
cancers (Friedl and Wolf, 2003). Another effect of reduced stiffness 
to EMT may arise in the generation of contractile forces that are 
FIGURE 7: LARG and GEF-H1 knockdowns decrease cell stiffness and stiffness response to force and increase cell 
migration and invasion. (A) NMuMG cells were transfected with siRNA against LARG, GEF-H1, both, or p114 for 48 h. 
Quantifications are given normalized to β-actin and relative to control, confirming knockdown of protein expression. 
(B) Average cell stiffness (G1) for NMuMG cells treated with siRNA control (n = 88), siRNA targeting p114 (n = 70), 
GEF-H1 (n = 90), LARG (n = 85), GEF-H1 + LARG (n = 100), and NMuMG cells treated with TGF-β and siRNA control 
(n = 69). *p < 0.01. Error bars represent SEM; data were collected from three independent experiments. (C) Average 
stiffness response at pulls 2 (G2/G1) and 8 (G8/G1) for NMuMG cells treated with siRNA control (n = 20), siRNA targeting 
p114 (n = 41), GEF-H1 (n = 19), LARG (n = 21), GEF-H1 + LARG (n = 30), and NMuMG cells treated with TGF-β and 
siRNA control (n = 19). #p < 0.05 stiffness difference from G1; *p < 0.05 stiffness response difference relative to cells 
treated with siRNA control. Error bars represent SEM; data were collected from three independent experiments. 
(D, E) Average migration and invasion for NMuMG cells treated with siRNA as indicated: control, GEF-H1, LARG, both, 
or p114 for 36 h before plating onto uncoated or Matrigel-coated Transwell filters. *p < 0.05. Error bars represent SEM; 
data represent mean of three independent experiments.
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application may enable, or increase the efficiency of, mechanosens-
ing mechanisms during cancer cell invasion.
EMT marks the physical initiation of cancer progression as a cell 
detaches from the primary tumor and invades the surrounding 
stromal space. Invasion is a complex process, however, and it is 
actomyosin-contractile forces (Plotnikov and Waterman, 2013). 
These forces are transmitted to the ECM via integrin adhesions and 
must act through an internal stiffness, which is likely the stiffness of 
the actin cytoskeleton network. Thus our results suggest that re-
duced stiffness and stiffening response post-EMT to external force 
FIGURE 8: LARG and GEF-H1 overexpression after EMT partially rescues cell stiffness and stiffness response and 
attenuates migration and invasion. (A) NMuMGs were treated with 100 pM TGF-β for 48 h. Cell were transfected with 
plasmid containing LARG-GFP or GEF-H1-GFP for the final 16–24 h of treatment. Quantifications are shown normalized 
to β-actin and relative to control, confirming protein expression. (B) Average cell stiffness (G1) for cells transfected with 
GFP vector control (n = 65), TGF-β and GFP vector control (n = 55), and GFP-DNA constructs to overexpress GEF-H1 
(n = 32) or LARG (n = 54). *p < 0.05 denotes stiffness difference relative to cells treated with TGF-β and GFP vector 
control. Error bars represent SEM; data were collected from three independent experiments. (C) Average force 
response at pulls 2 (G2/G1) and 8 (G8/G1) for NMuMG cells transfected with GFP vector control (n = 25), TGF-β and GFP 
vector control (n = 15), and GFP-DNA constructs to overexpress GEF-H1 (n = 16) or LARG (n = 23). #p < 0.05 denotes 
stiffness difference from G1; *p < 0.05 denotes stiffness response difference relative to cells treated with TGF-β and 
GFP vector control. Error bars represent SEM; data were collected from three independent experiments. (D, E) Average 
migration and invasion for cells treated with TGF-β and transfected with plasmid containing empty vector control (GFP), 
LARG-GFP, or GEF-H1 GFP for the final 16–24 h of treatment and sorted by flow cytometry for GFP expression. 
Quantifications given as fold migration or invasion relative to control (n = 3). *p < 0.05.
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and that the down-regulation of these proteins facilitates cell inva-
sion. Our results connect for the first time the origin of the stiffness 
and invasion relationship to EMT and highlight the importance of 
mechanics and physical forces in cancer cell invasion.
MATERIALS AND METHODS
Cell culture and transfection
NMuMG cells were maintained in high-glucose DMEM (Life Technolo-
gies) containing 10% fetal bovine serum (FBS), 10 μg/ml insulin, peni-
cillin/streptomycin (Life Technologies, Carlsbad, CA), and 15 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer. 
PANC-1 cells were maintained in high-glucose DMEM (Life Technol-
ogies) containing 10% FBS, penicillin/streptomycin, and 15 mM 
HEPES buffer. OVCA420 cells were maintained in RPMI containing 
10% FBS and penicillin/streptomycin. The NMuMG, PANC-1 and 
OVCA420 cell lines were maintained as described previously 
(Elbendary et al., 1994; Kowanetz et al., 2004; Gordon et al., 2009).
Immunoblotting
Cell lysates were prepared in Laemmli sample buffer. Before load-
ing, they were heated at 95°C for 5–10 min and centrifuged at 
13,000 rpm for 1 min. Samples were resolved by 12% SDS–PAGE for 
RhoA or 7.5% SDS–PAGE for other proteins. Proteins were trans-
ferred to nitrocellulose or Immobilon-FL membranes, blocked with 
Odyssey blocking buffer (LI-COR), and then immunoblotted with 
primary antibodies overnight. Fluorophore-conjugated secondary 
antibodies were used to bind primary antibodies, and fluorescence 
was detected and quantified using the Odyssey system (LI-COR).
The following antibodies were used: GEF-H1 (1:1000; 4076S; 
Cell Signaling Technology, Danvers, MA), LARG (1:1000; ab86095; 
Abcam, Cambridge, UK), p114 (1:1000; a gift from Keith Burridge, 
University of North Carolina at Chapel Hill), RhoA (1:1000; 2117; 
Cell Signaling Technology), E-cadherin (1:1000; 610182; BD Trans-
duction: BD Biosciences, San Jose, CA), smooth muscle actin 
(1:2500; A5228; Sigma-Aldrich), and β-actin (1:2500; A5441; Sigma-
Aldrich).
Real-time PCR
Cells were plated and treated in six-well plates. Total RNA was har-
vested using the RNeasy Mini Kit (Qiagen, Venlo, Netherlands), and 
600 ng of RNA per sample was reverse transcribed to cDNA using 
the iScript cDNA Synthesis Kit (Bio-Rad). Real-time (RT) PCR was 
then performed by mixing iQ SYBR Green Supermix (Bio-Rad, 
Hercules, CA) with the respective forward and reverse primers. The 
following primers were used for RT-PCR:
GEF-H1 forward: 5′-CAG TTT GAG AGG AAC CCG GC-3′
GEF-H1 reverse: 5′-ACT CCT CCC AGA TCA AGG CA-3′
LARG forward: 5′-GGG ACC GAA GCC GAC G-3′
LARG reverse: 5′-TTC GTC ACA GAG GGA AGT CG-3′
P114 forward: 5′-CTA GAG GAG GGC AGT GAT CG-3′
P114 reverse: 5′-CCT TCA TTC TCT CCC CGG TT-3′
E-cadherin forward: 5′-CCT TCC CCC AAC ACG TCC CCC C-3′
E-cadherin reverse: 5′-TCT CCA CCT CCT TCT TCA TC-3′
GAPDH forward: 5′-TTG ACC TCA ACT ACA TGG TCT A-3′
GAPDH reverse: 5′-ACC AGT AGA CTC CAC GAC ATA C-3′
RNA interference and vector overexpression
siRNAs were purchased from Thermo Scientific. Cells were trans-
fected with siRNA using Lipofectamine 2000 (Invitrogen, Carlsbad, 
known that cancer cells can adjust between amoeboid and mesen-
chymal motility modes depending on the particular ECM environ-
ment (Wolf et al., 2003; Sanz-Moreno et al., 2008; Sanz-Moreno and 
Marshall, 2010). During EMT, generally immobile epithelial cells ac-
quire mesenchymal motility, characterized by protease-dependent 
degradation of the ECM, Rac1 GTPase-regulated lamellipodial pro-
trusions at the leading edge, and tightly controlled and appropriate 
RhoA- and RhoC-dependent actomyosin contractility at the cell rear 
that results in disassembly of FAs and retraction of the trailing edge 
(Yilmaz and Christofori, 2009). Although evidence indicates that the 
GEF/RhoA pathway is altered in numerous cancers (Simpson et al., 
2004; Vega et al., 2011), its role is complicated, with often conflict-
ing reported results. RhoA activation in some cancers is associated 
with increased invasion (Liao et al., 2012), whereas in other models, 
its activation inhibits cell invasion (Bellovin et al., 2006). Studies us-
ing HeLa cells (Nalbant et al., 2009) and retinal pigment epithelia 
cells (Tsapara et al., 2010) showed that GEF-H1 mediates cell migra-
tion in wound-healing assays and standard invasion assays. Another 
group used NMuMG cells and found that GEF-H1 is required for 
invasion across compliant collagen gels (Heck et al., 2012). Of inter-
est, observations in keratinocytes have shown that the RhoA GEF 
Net1A is specifically down-regulated during TGF-β–induced EMT 
(Papadimitriou et al., 2011). Furthermore, work with human breast 
cancer cells suggests that regulation of RhoA by GEFs alone may 
initiate EMT invasion, as mesenchymal invasion was promoted over 
amoeboid by knockdown of either Net1A or RhoA (Carr et al., 2013). 
We find that LARG and GEF-H1 are down-regulated during EMT 
(TGF-β and BMP-2 induced) in multiple epithelial models. In addi-
tion, silencing expression of LARG and GEF-H1 increases invasive 
capacity toward that of post-EMT mesenchymal cells. Our data are 
consistent with a model in which mesenchymal invasion occurs con-
currently with decreased stiffness and is mediated via TGF-β regula-
tion of RhoA activity to enable passage through the basement 
membrane and ECM required during EMT.
TGF-β mediates cellular functions during EMT via both canoni-
cal Smad-dependent pathways, as well as by noncanonical Smad-
independent pathways, with canonical pathways typically being 
downstream of the type I TGF-β receptor (ALK5). Mechanisms of 
TGF-β regulation include alterations of gene transcription 
(Massagué, 2012), microRNA-mediated translational silencing 
(Winter et al., 2009), and enhanced proteasome degradation via 
increased polyubiquitination (Ozdamar et al., 2005). We estab-
lished that TGF-β enhances proteasomal degradation of LARG and 
GEF-H1 via an ALK5-dependent pathway and that microRNAs do 
not seem to play a prominent role in the regulation of these GEFs. 
TGF-β was previously reported to target Net1A, another RhoA 
GEF, for proteasome degradation, although translational silencing 
by miR-24 also contributes to its down-regulation (Papadimitriou 
et al., 2011). Of interest, TGF-β has also been shown to target 
RhoA for proteasome degradation by activating the ubiquitin li-
gase Smurf1 via polarity protein Par6 (Ozdamar et al., 2005). Tight 
spatial and temporal regulation of RhoA and associated GEFs by 
TGF-β is crucial during the EMT program. Early in EMT, loss of 
RhoA activation and destabilization of microtubules at the basal 
surface of epithelial cells causes loss of cell–basement membrane 
interactions (Nakaya et al., 2008). Of interest, transient up-regula-
tion of Net1A has been shown to be required for EMT initiation, 
but by 24 h, Net1A levels are subsequently depleted as the cell 
progresses through EMT (Papadimitriou et al., 2011), perhaps to 
allow cells to acquire mesenchymal motility as discussed earlier.
In this work, we established that LARG and GEF-H1 down-regu-
lation is critical for the mechanical alterations that occur during EMT, 
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recording bead trajectories and computing bead velocities, we used 
Stokes’ law, F = 6πaηv, to determine the force, where a is the bead 
radius, η is the fluid viscosity, and v is the bead velocity. Knowledge 
of the bead displacement r(t) and the applied force F(t) allowed us 
to compute the compliance signature, J(t) = 6πar(t)/F(t), which we 
then fitted to a Jeffrey (modified Kelvin–Voigt) mechanical circuit 
model for viscoelastic liquids. The spring constant is reported as the 
stiffness in pascals. The ability of a cell to locally respond to applied 
force, termed the stiffness response, was computed by normalizing 
stiffness values of subsequent force pulses to the stiffness. Two types 
of force response were observed: a stiffening response, for which 
Gn1/G1 > 1 (Supplemental Figure S1A), and a softening response, 
for which Gn1/G1 < 1 (Supplemental Figure S1B). Mechanical mea-
surements were taken for 1 h after 20 min of bead incubation. To 
minimize unintentional force application, measurements were taken 
only for cells spaced several hundred micrometers apart. In addi-
tion, bead displacements below system resolution (10 nm) and 
greater than the diameter of the bead (4.5 μm) were not included in 
the analysis. Mechanical measurements are reported as the mean ± 
SEM.
Rotating permanent magnet and adhesion complex 
recruitment assay
To closely link force-dependent biology results from mechanical 
(magnetic tweezers) and biochemical approaches (protein expres-
sion and recruitment), we engineered a rotating permanent mag-
net system designed to be lowered into a standard 10–cm cell cul-
ture dish (Supplemental Figure S2A). A DC motor (ServoCIty, 
Winfield, KS) was used to rotate two custom-made, axially magne-
tized, 120° arc magnets (N52 grade; K&J Magnetics, Pipersville, 
PA) at 4 rpm at a height of 16 mm above the cells to generate a 
time-varying force of a magnitude (50 pN), duty cycle (5 s of force 
every 15 s, or 33%), and frequency (6.7 mHz) consistent with the 
force regimen used with the magnetic tweezers (Supplemental 
Figure S2B). To validate the device, we used engineering software 
(COMSOL Multiphysics) to simulate the magnetic field gradient 
and MATLAB to calculate the resulting force, given the material 
properties of the magnetic beads (Supplemental Figure S2B).
For the adhesion complex recruitment assay, cells were plated 
onto 10-cm dishes and treated with 100 pM TGF-β or not for 48 h. 
They were then incubated for 30 min at 37°C in serum-free medium 
with FN-coated magnetic beads. Force was applied using a rotating 
magnet described later. Immediately after force application, cells 
were lysed in ice-cold lysis buffer (20 mM Tris, 150 mM NaCl, 2 mM 
MgCl2, 1% NP-40, inhibitors). Beads were isolated from the lysate 
using a magnetic separation stand. The lysate was clarified with cen-
trifugation at 13,000 rpm for 15 min at 4°C. Proteins in both frac-
tions were denatured and reduced in Laemmli buffer.
Passive microrheology mechanical assay
Passive microrheology measurements used nonmagnetic beads 
(2 μm; Invitrogen) coated with fibronectin. Video data were acquired 
at 54 frames/s using an automated microscope system described 
previously (Spero et al., 2008). Brownian motion of the beads was 
tracked using CISMM Video Spot Tracker software, and the mean 
squared displacement (MSD) of the trajectories was computed using
r x t x t y t y t< ( )> <MSD> <[ ( + ) ( )] [ ( + ) ( )] >2 2 2τ = = τ − + τ −
where t is the elapsed time and τ is the time lag, or time scale. The 
stiffness of the cell, or the elastic modulus, was computed from the 
MSD using the generalized Stokes–Einstein relation (GSER). In short, 
the frequency-dependent elastic modulus was calculated using
CA). siRNA was mixed with Lipofectamine 2000 reagent in Opti-
MEM media (Life Technologies) at manufacturer-recommended 
concentrations. The transfection media was removed after 12 h, and 
RNA interference was allowed to proceed for a total of 48 h. The 
following siRNAs were used.
Scramble nontargeting control (Thermo Scientific ON-TARGET 
plus D-001810-01-05):
Anti–GEF-H1: 5′-GGG CGA CGC UUU AUA CUU G-3′
Anti-LARG: 5′-GAU UAC AAC CGA ACG GCU A-3′
DNA plasmid transfection for overexpression assays was also 
carried out using Lipofectamine 2000. DNA was mixed with Lipo-
fectamine 2000 reagent in Opti-MEM at the manufacturer-recom-
mended concentrations. The transfection medium was removed 
after 12 h, and overexpression was allowed to continue for 48–72 h. 
Overexpressed proteins were GFP-tagged at the N-terminus. To 
select for cells overexpressing the protein of interest, we performed 
FACS for GFP-expressing cells. GEF-H1 cDNA was cloned into a 
PEGFP-n1 vector, and LARG cDNA was cloned into a pENTR 2B 
vector (Invitrogen).
RhoA activity assay
Cells were plated onto 10-cm dishes and treated with 100 pM TGF-β 
or not for 48 h. They were then incubated with fibronectin-coated 
magnetic beads and subject to force as described. Immediately af-
ter force application, cells were lysed in ice-cold lysis buffer (50 mM 
Tris, pH 7.4, 10 mM MgCl2, 500 mM NaCl, 0.1% SDS, 0.5% deoxy-
cholate, 200 μM sodium orthovanadate, 1% Triton X, inhibitors). The 
lysis reaction was allowed to proceed for 30 min in a rotator at 4°C. 
Beads and cell debris were then separated via centrifugation at 
13,000 rpm for 15 min at 4°C. The clarified lysate was incubated 
with 30 μg of Rhotekin-RBD beads (Cytoskeleton, Denver, CO) for 
1 h in a rotator at 4°C. The bead and lysate fractions were then sepa-
rated via centrifugation at 5000 rpm for 2 min. The bead fractions 
were washed three times with wash buffer (50 mM Tris, pH 7.4, 
10 mM MgCl2, 150 mM NaCl, 1% Triton-X, inhibitors), and samples 
were prepared for SDS–PAGE with Laemmli sample buffer. The 
lysate fractions were also prepared for SDS–PAGE with Laemmli 
sample buffer.
Preparation of paramagnetic beads
Tosyl-activated magnetic Dynabeads (4.5 μm; Invitrogen) were incu-
bated with FN for 1 h at room temperature on a spinning rotator. 
Beads were centrifuged and resuspended in a 10% Tris solution 
(0.86 M, 7.4 pH) to quench unoccupied tosyl groups on the bead 
surface. After 45 min of rotation at room temperature or overnight 
at 4°C, bead were concentrated again and resuspended in phos-
phate-buffered saline (PBS). Beads were vortexed or sonicated be-
fore use to prevent aggregation.
Magnetic tweezers mechanical assay
The University of North Carolina three-dimensional force micro-
scope was used as a magnetic tweezers system to apply a 50-pN 
force pulse for 5 s, followed by a 10-s relaxation, to fibronectin-
coated magnetic beads (4.5-μm diameter). The time-dependent 
displacement of bound beads was recorded using a high-speed 
video camera at 30 frames/s (Pulnix; JAI) and was tracked using 
CISMM Video Spot Tracker software (Center for Computer Inte-
grated Systems for Microscopy and Manipulation [http://cismm 
.cs.unc.edu]). Before experiments began, we calibrated the mag-
netic tweezers system by applying a force ramp to magnetic beads 
(4.5-μm diameter) in a Newtonian fluid of known viscosity. By 
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where the magnitude of the complex viscoelastic modulus is 
given by
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Γ is the gamma function, and α is the local logarithmic slope of 
<r2(τ)>. Values for G′ at a time lag of 1 s, the maximum time scale 
where thermal fluctuations are predominately Brownian, are re-
ported as stiffness in pascals. Owing to computational challenges in 
evaluating statistical significance in the GSER formulism, statistical 
analysis was performed on the value of the MSD at the 1-s time 
scale to evaluate differences between cell populations.
Matrigel invasion and Transwell migration assays
Cells were trypsinized and seeded at a density of 50,000 cells/well 
on either Matrigel-coated (BD Biosciences) or uncoated (Corning) 
Transwell filters in a 24-well plate and allowed to invade for 12 h 
toward 10% FBS in the lower chamber. Cells invading and migrating 
through the Matrigel-coated and uncoated filters, respectively, were 
stained with Three Step stain (Richard-Allan Scientific). Each filter 
was counted in its entirety with four 10× fields, and invasion or mi-
gration was quantified as fold relative to control.
Immunofluorescence staining
Cells were plated onto coverslips at a sparse density. They were 
fixed with 4% paraformaldehyde for 5 min with 0.1% Triton-X in PBS 
and blocked with 1% BSA in PBS. Alexa Fluor 594 Phalloidin (Invit-
rogen) was then used to stain for actin. Stained cells on coverslips 
were then mounted onto slides using ProLong Gold Anti-Fade 
Reagent (Invitrogen) and imaged on a fluorescence microscope with 
a 40× air objective.
Statistical analysis
Measurements are reported as the mean ± SEM, and differences 
between conditions were analyzed with either a two-tailed, unpaired 
Student’s t test or a two-tailed, paired Student’s t test for difference 
measurements between corresponding samples.
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